These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9880564)

  • 1. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.
    Wang X; Driscoll DM; Morton RE
    J Biol Chem; 1999 Jan; 274(3):1814-20. PubMed ID: 9880564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids.
    Morton RE; Greene DJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3041-8. PubMed ID: 9409291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
    Serdyuk AP; Morton RE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).
    Paromov VM; Morton RE
    J Biol Chem; 2003 Oct; 278(42):40859-66. PubMed ID: 12907677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity of various non-esterified fatty acids to suppress lipid transfer inhibitor protein activity is related to their perturbation of the lipoprotein surface.
    Morton RE; Greene DJ
    Biochim Biophys Acta; 2000 Jul; 1486(2-3):275-84. PubMed ID: 10903478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.).
    Kushwaha RS; Hasan SQ; McGill HC; Getz GS; Dunham RG; Kanda P
    J Lipid Res; 1993 Aug; 34(8):1285-97. PubMed ID: 8409763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL.
    Morton RE; Greene DJ
    J Lipid Res; 2003 Dec; 44(12):2287-96. PubMed ID: 12951364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels.
    Morton RE; Nunes V; Izem L; Quintão E
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1642-9. PubMed ID: 11597939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: relationship between association properties and inhibitory activities.
    Cho KH; Lee JY; Choi MS; Bok SH; Park YB
    Lipids; 2002 Jul; 37(7):641-6. PubMed ID: 12216834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia.
    Izem L; Morton RE
    J Lipid Res; 2009 Apr; 50(4):676-84. PubMed ID: 19008550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.
    He Y; Greene DJ; Kinter M; Morton RE
    J Lipid Res; 2008 Jul; 49(7):1529-37. PubMed ID: 18369235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein.
    Nishide T; Tollefson JH; Albers JJ
    J Lipid Res; 1989 Feb; 30(2):149-58. PubMed ID: 2715721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.
    Morton RE; Greene DJ
    J Lipid Res; 2011 Dec; 52(12):2262-2271. PubMed ID: 21937674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.
    Morton RE; Liu Y; Izem L
    J Lipid Res; 2019 Nov; 60(11):1868-1879. PubMed ID: 31511396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.
    Morton RE; Greene DJ
    J Lipid Res; 1994 May; 35(5):836-47. PubMed ID: 8071606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity.
    Gautier T; Masson D; de Barros JP; Athias A; Gambert P; Aunis D; Metz-Boutigue MH; Lagrost L
    J Biol Chem; 2000 Dec; 275(48):37504-9. PubMed ID: 10978346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.
    Liu Y; Morton RE
    Curr Opin Lipidol; 2020 Aug; 31(4):194-199. PubMed ID: 32520778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma.
    Morton RE; Steinbrunner JV
    Arterioscler Thromb; 1993 Dec; 13(12):1843-51. PubMed ID: 8241106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced detection of lipid transfer inhibitor protein activity by an assay involving only low density lipoprotein.
    Morton RE; Greene DJ
    J Lipid Res; 1994 Nov; 35(11):2094-9. PubMed ID: 7868987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.